These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 21543745)

  • 1. NP603, a novel and potent inhibitor of FGFR1 tyrosine kinase, inhibits hepatic stellate cell proliferation and ameliorates hepatic fibrosis in rats.
    Lin N; Chen S; Pan W; Xu L; Hu K; Xu R
    Am J Physiol Cell Physiol; 2011 Aug; 301(2):C469-77. PubMed ID: 21543745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver.
    He W; Shi F; Zhou ZW; Li B; Zhang K; Zhang X; Ouyang C; Zhou SF; Zhu X
    Drug Des Devel Ther; 2015; 9():3989-4104. PubMed ID: 26347199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardin and myocardin-related transcription factor-A synergistically mediate actin cytoskeletal-dependent inhibition of liver fibrogenesis.
    Shi Z; Ren M; Rockey DC
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G504-G517. PubMed ID: 31928221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of growth factor receptor-bound 2 in CCl
    Ge S; Xiong Y; Wu X; Xie J; Liu F; He J; Xiang T; Cheng N; Lai L; Zhong Y
    Biomed Pharmacother; 2017 Aug; 92():942-951. PubMed ID: 28618656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,3'-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression.
    Zhang Z; Gao Z; Hu W; Yin S; Wang C; Zang Y; Chen J; Zhang J; Dong L
    Br J Pharmacol; 2013 Oct; 170(3):649-60. PubMed ID: 23902531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway.
    Cai S; Wu L; Yuan S; Liu G; Wang Y; Fang L; Xu D
    Eur J Pharmacol; 2021 May; 898():173982. PubMed ID: 33647257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
    Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
    J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Src family kinase member Fyn by Saracatinib attenuated liver fibrosis in vitro and in vivo.
    Du G; Wang J; Zhang T; Ding Q; Jia X; Zhao X; Dong J; Yang X; Lu S; Zhang C; Liu Z; Zeng Z; Safadi R; Qi R; Zhao X; Hong Z; Lu Y
    Cell Death Dis; 2020 Feb; 11(2):118. PubMed ID: 32051399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-fibrotic activity and enhanced interleukin-6 production by hepatic stellate cells in response to imatinib mesylate.
    Kim Y; Fiel MI; Albanis E; Chou HI; Zhang W; Khitrov G; Friedman SL
    Liver Int; 2012 Jul; 32(6):1008-17. PubMed ID: 22507133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRPM7 channel regulates PDGF-BB-induced proliferation of hepatic stellate cells via PI3K and ERK pathways.
    Fang L; Zhan S; Huang C; Cheng X; Lv X; Si H; Li J
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):713-25. PubMed ID: 23958495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion.
    Wu Y; Liu X; Zhou Q; Huang C; Meng X; Xu F; Li J
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):163-76. PubMed ID: 26435214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
    Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifibrotic effects of luteolin on hepatic stellate cells and liver fibrosis by targeting AKT/mTOR/p70S6K and TGFβ/Smad signalling pathways.
    Li J; Li X; Xu W; Wang S; Hu Z; Zhang Q; Deng X; Wang J; Zhang J; Guo C
    Liver Int; 2015 Apr; 35(4):1222-33. PubMed ID: 25040634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Babao Dan attenuates hepatic fibrosis by inhibiting hepatic stellate cells activation and proliferation via TLR4 signaling pathway.
    Liang L; Yang X; Yu Y; Li X; Wu Y; Shi R; Jiang J; Gao L; Ye F; Zhao Q; Li R; Wei L; Han Z
    Oncotarget; 2016 Dec; 7(50):82554-82566. PubMed ID: 27776340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
    Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
    Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.
    Wang Y; Gao J; Zhang D; Zhang J; Ma J; Jiang H
    J Hepatol; 2010 Jul; 53(1):132-44. PubMed ID: 20447716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gan Shen Fu Fang ameliorates liver fibrosis
    Du QH; Zhang CJ; Li WH; Mu Y; Xu Y; Lowe S; Han L; Yu X; Wang SY; Li Y; Li J
    World J Gastroenterol; 2020 Jun; 26(21):2810-2820. PubMed ID: 32550756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.
    Liu Y; Wang Z; Wang J; Lam W; Kwong S; Li F; Friedman SL; Zhou S; Ren Q; Xu Z; Wang X; Ji L; Tang S; Zhang H; Lui EL; Ye T
    Liver Int; 2013 Apr; 33(4):504-15. PubMed ID: 23279742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling.
    Liu Y; Lui EL; Friedman SL; Li L; Ye T; Chen Y; Poon RT; Wo J; Kok TW; Fan ST
    Lab Invest; 2009 Feb; 89(2):209-21. PubMed ID: 19114984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifibrotic effects of magnesium lithospermate B on hepatic stellate cells and thioacetamide-induced cirrhotic rats.
    Paik YH; Yoon YJ; Lee HC; Jung MK; Kang SH; Chung SI; Kim JK; Cho JY; Lee KS; Han KH
    Exp Mol Med; 2011 Jun; 43(6):341-9. PubMed ID: 21499011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.